AstraZeneca pledges $2.5B for R&D center in Beijing



AstraZeneca announced on Friday the investment of $2.5 billion in Beijing to establish its second strategic research and development (R&D) center in China and sixth worldwide. AstraZeneca projects…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento